Rowland & CO Investment Counsel Bio Rad Laboratories, Inc. Transaction History
Rowland & CO Investment Counsel
- $486 Million
- Q3 2024
A detailed history of Rowland & CO Investment Counsel transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 883 shares of BIO stock, worth $292,158. This represents 0.06% of its overall portfolio holdings.
Number of Shares
883
Previous 978
9.71%
Holding current value
$292,158
Previous $267,000
10.49%
% of portfolio
0.06%
Previous 0.06%
Shares
17 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$513 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$431 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$359 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$236 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.15B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...